MDI and DPI Drug Products
...an internal reservoir containing sufficient formulation for multiple doses that are.....recommended for inclusion in the application regarding the components, manufacturing.....formulation, moisture level, consistency of filling operation, particle size distribution..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)

FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...The composition of an MDI formulation and the physicochemical content of each of the formulation.....The composition and physicochemical characteristics of the formulation and components of a DPI have a.....In the manufacture of TDS products, the components of the formulation, vehicle, adhesive, and penetration..
http://www.fda.gov/cder/fdama/difconc.htm (score=71)

þÿ
...formulation components or leaching from the container closure system, chemical impurities.....system components are critical to ensure the quality and purity of the drug product and.....practicable, the leaching and entry of chemical contaminants into the drug formulation. 94..
http://www.fda.gov/cder/guidance/4168dft.pdf (score=67)

Microsoft Word - 3640fnl.doc
...recommends that a switch to a cream formulation from an ethanolic solution generally be.....formulation components that absorb UVB, UVA, or visible radiation (290-700 nm) and(1) are directly.....effects of other components in the formulation and (1) increase epidermal thickening..in..
http://www.fda.gov/cder/guidance/3640fnl.pdf (score=39)

...For example, the Agency recommends that a switch to a cream formulation from an ethanolic.....Vehicles can enhance the effects of other components in the formulation and (1) increase.....Studies of dermal absorption of the drug substance for one formulation do not necessarily..
http://www.fda.gov/cder/guidance/3640fnl.doc (score=39)

Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products...
...The composition of the formulation of a DPI has a direct effect on the stability of the.....Furthermore, modification or alteration of these products due to changes in components of.....The fraction of the formulation delivered to the patient consists of a mixture of..
http://www.fda.gov/CDER/GUIDANCE/2180dft.htm (score=39)

Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products...
...The components should be compatible with the formulation, and their functionality should be well established to ensure ruggedness.....The composition of the formulation of a DPI has a direct effect on the stability of the.....Furthermore, modification or alteration of these products due to changes in components of..
http://www.fda.gov/cder/guidance/2180dft.htm (score=39)

þÿ
...formulation components or leaching from the container closure system, chemical impurities.....system components are critical to ensure the quality and purity of the drug product and.....practicable, the leaching and entry of chemical contaminants into the drug formulation. 94..
http://www.fda.gov/cder/guidance/4168dft.PDF (score=39)

þÿ
...2 A liposomal formulation of an active moiety that has already been approved or marketed.....The quality and purity of the lipid components can affect the quality of the liposome drug.....formulation is intended to exhibit a different pharmacokinetic and/or tissue distribution..
http://www.fda.gov/cder/guidance/2191dft.pdf (score=38)

þÿ
...matter can originate during manufacturing, from formulation components,and from the container and.....discoloration of the formulation, distortion of pump components, pump clogging,and adherence of the drug to the walls of.....and components are used for reproducible delivery of drug formulation,and these can be..
http://www.fda.gov/cder/guidance/4234fnl.pdf (score=38)

þÿ
...The need for routine testing of the final formulation depends on..the product, and.....be employed where appropriate, to evaluate any adverse effects of product formulation.. components on.....microbiologically effective by performing a microbial challenge test of the formulation..
http://www.fda.gov/cder/guidance/3226dft.pdf (score=38)

þÿ
...4 Safety evaluations of inactive formulation components should be conducted to determine potential.....can be important to include the pediatric clinical formulation's inactive ingredients in.....Issues related to formulation should be discussed with the Agency.Toxicological assessment..
http://www.fda.gov/cder/guidance/3816dft.PDF (score=38)

Guidance for Industry: Chronic Cutaneous Ulcer and Burn Wounds -Developing...
...Products that will be delivered in an aerosol formulation should be evaluated for.....formulation components on wound healing. Cutaneous irritation and hypersensitivity testing are.....The need for routine testing of the final formulation depends on the product, and sponsors..
http://www.fda.gov/cber/gdlns/ulcburn.htm (score=38)

Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products -...
...Particulate matter can originate during manufacturing, from formulation components, and from the.....The formulation and container closure system components of the three primary stability batches should be the same as those intended.....color and clarity of formulation, size and shape of pump components, texture of inside of..
http://www.fda.gov/cder/guidance/4234fnl.htm (score=38)

Chronic Cutaneous Ulcer and Burn Wounds - Developing Products for Treatment
...Products that will be delivered in an aerosol formulation should be evaluated for.....formulation components on wound healing. Cutaneous irritation and hypersensitivity testing are.....The need for routine testing of the final formulation depends on the product, and sponsors..
http://www.fda.gov/cder/guidance/3226dft.htm (score=38)

...In limited circumstances, it can be important to include the pediatric clinical.....4] Safety evaluations of inactive formulation components should be conducted to determine potential.....Issues related to formulation should be discussed with the Agency. Toxicological..
http://www.fda.gov/cder/guidance/3816dft.doc (score=38)

Guidance for Industry Chronic Cutaneous Ulcer and Burn Wounds - Developing...
...The need for routine testing of the final formulation depends on..the product, and.....be employed where appropriate, to evaluate any adverse effects of product formulation.. components on.....microbiologically effective by performing a microbial challenge test of the formulation..
http://www.fda.gov/cber/gdlns/ulcburn.pdf (score=38)

Premarin
...This unexpected characteristic of the Premarin formulation meant that generic copies were.....Consequently, not all components that "furnish pharmacological activity or other direct.....In most cases, it will be clear what components of a drug make clinically meaningful..
http://www.fda.gov/cder/news/celetterjw.htm (score=12)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...accelerator operation, radiochemical synthesis, purification steps, and formulation of the.....evaluation can include testing of the material (see Section VI, Control of Components, 276.....how to conduct each test for components, in-process materials, and finished products. 1112..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=12)

Las Vegas Injury Lawyer